Composition
- Active ingredients
- RANITIDINE HYDROCHLORIDE EQ 300MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- RANITIDINE HYDROCHLORIDE EQ 300MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletThis page
- RANITIDINE HYDROCHLORIDE EQ 300MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CapsuleNDA020095-002 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA018703.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Zantac 300
- Active substance
- ranitidine hydrochloride
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Glaxo GRP LTD
- Status
- Discontinued
- FDA approval
- 9 Jun 1983
- Application
- NDA018703-002